CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Major Compliance Challenges Facing The Life Science Industry In 2022

Major Compliance Challenges Facing...

How Pharmaceutical Automation is Revolutionizing Drug Development

How Pharmaceutical Automation is...

Major Challenges In The Evolving Era Of Life Sciences

Major Challenges In The Evolving Era...

Exeevo Brings Innovative Hybrid/Remote Connectivity With Native Integration Into The Omnipresence Customer Relationship Platform, Powered By Microsoft Teams

Exeevo Brings Innovative...

Key Trends in Life Sciences Compliances to Watch out for in 2022

Key Trends in Life Sciences...

Four Proven Pharmaceutical Marketing Strategies to Know

Four Proven Pharmaceutical Marketing...

Key Compliance Challenges Facing Life Science Industry

Key Compliance Challenges Facing Life...

Bruker introduces TOF SCP and TOF Pro 2 for unmatched proteomic dept.

Bruker introduces TOF SCP and TOF Pro...

Major Compliance Challenges Facing The Life Science Industry In 2022

Major Compliance Challenges Facing...

How Pharmaceutical Automation is Revolutionizing Drug Development

How Pharmaceutical Automation is...

Major Challenges In The Evolving Era Of Life Sciences

Major Challenges In The Evolving Era...

Exeevo Brings Innovative Hybrid/Remote Connectivity With Native Integration Into The Omnipresence Customer Relationship Platform, Powered By Microsoft Teams

Exeevo Brings Innovative...

Key Trends in Life Sciences Compliances to Watch out for in 2022

Key Trends in Life Sciences...

Four Proven Pharmaceutical Marketing Strategies to Know

Four Proven Pharmaceutical Marketing...

Key Compliance Challenges Facing Life Science Industry

Key Compliance Challenges Facing Life...

Bruker introduces TOF SCP and TOF Pro 2 for unmatched proteomic dept.

Bruker introduces TOF SCP and TOF Pro...

Major Risk Considerations for Life Sciences Industry

Life Sciences Review | Thursday, February 18, 2021
Tweet

Establishing and maintaining an in-house team, leading life sciences organizations periodically fill compliance gap assessments and enhance monitoring programs.


FREMONT, CA: The life sciences industry faces several existing and emerging challenges from a regulatory and compliance perspective, posing a constant threat to sustainability processes. Companies that can effectively handle these concerns can take a more proactive stance on risk, stick to evolving regulatory standards and ultimately create a competitive advantage. The following are key takeaways that life sciences organizations should consider to deploy controls that promote compliance and deter fraud and corruption.


Regulatory enforcement in the life sciences industry continues to increase, forcing firms to continually evaluate their risk and assess their present compliance programs' adequacy. Due to the present regulatory environment, life sciences firms must take steps to know new and emerging risks to rapidly respond and adapt. This latest scrutiny has resulted in a dramatic rise in defendants charged in health-care-related fraud cases. Given the increased regulatory enforcement activities, life sciences firms should be mindful of risks and create controls that limit malicious activities. 


Check Out: Top Pharma and Life Science Consulting Companies


Life sciences firms are particularly susceptible in a few specific areas.


The European Union’s General Data Protection Regulation (GDPR) needs all firms that hold, transmit or process EU data to comply with the law, regardless of whether firms or contracted third parties function in the EU. GDPR raises the bar for securing consumer information and needs specific tracking from collection to disposal. To address these and data security concerns, firms should periodically audit security and privacy strategies, amend controls and planning as required, align governance appropriately and have an incident response plan in place.


Due to the nature of their business, life sciences firms encounter more bribery and corruption than other industry segments. These firms often must interact with foreign and domestic governmental entities and officials, inherently generating higher public corruption risks. Also, many firms continue to assess their compliance and internal audit functions to decide whether their resources have adequate knowledge and experience. Regulatory authorities look favorably upon firms who have actively taken steps to follow guidance and deploy effective programs.


Weekly Brief

loading
Top 10 Life Science Compliance Solution Companies - 2021
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/major-risk-considerations-for-life-sciences-industry--nwid-262.html